Barham Abudayyeh joins Qaelon Scientific Advisory Board

STRASBOURG, France, March 25, 2026 -- We are pleased to welcome Barham Abudayyeh MD MPH to Qaelon Medical's Scientific Advisory Board. Dr. Abu Dayyeh is a globally recognized leader in advanced endoscopy and endobariatrics, with 𝗱𝗲𝗲𝗽 𝗲𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗶𝗻 𝗺𝗶𝗻𝗶𝗺𝗮𝗹𝗹𝘆 𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗮𝗻𝗱 𝗼𝗿𝗴𝗮𝗻-𝘀𝗽𝗮𝗿𝗶𝗻𝗴 𝗚𝗜 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀. At Cedars-Sinai, he serves as Executive Director and Associate Dean for Innovation and Director of Interventional Gastroenterology, where he leads clinical and translational efforts at the forefront of endoluminal and metabolic therapies. 

 Barham Abudayyeh MD MPH

Dr. Abu Dayyeh is one of the most 𝗶𝗻𝗳𝗹𝘂𝗲𝗻𝘁𝗶𝗮𝗹 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗼𝗿𝘀 𝗶𝗻 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝗮𝗹 𝗴𝗮𝘀𝘁𝗿𝗼𝗲𝗻𝘁𝗲𝗿𝗼𝗹𝗼𝗴𝘆 𝗮𝗻𝗱 𝗲𝗻𝗱𝗼𝗹𝘂𝗺𝗶𝗻𝗮𝗹 𝘀𝘂𝗿𝗴𝗲𝗿𝘆 𝗴𝗹𝗼𝗯𝗮𝗹𝗹𝘆, combining the perspective of a high-volume advanced endoscopist, inventor, startup founder, and institutional innovation leader. He is a pioneer in endoscopic pulsed electric field (PEF) therapy and the co-inventor of Endogenex, translating this technology into novel endoscopic treatments for metabolic disease. He serves on the board of the American Foregut Society Bariatric Committee, and was the lead author of the MERIT trial, a landmark study advancing endoscopic approaches for obesity and metabolic disease. 

“As we push the boundaries of endoluminal and metabolic therapies, the next phase of innovation will depend on integrating objective data into how we evaluate and guide these procedures,” said Dr. Abu Dayyeh. “Qaelon’s approach introduces a new layer of intraoperative insight that has the potential to enhance procedural confidence, standardize outcomes, and accelerate the evolution of less invasive, organ-sparing treatments.” 

“We are thrilled to welcome Barham to our Scientific Advisory Board,” said Lee Swanstrom, President of Qaelon Medical. “Barham has been at the forefront of developing and driving the adoption of new endoluminal technologies and therapies globally. His unique ability to bridge innovation, clinical practice, and commercialization will be instrumental as we advance Qaelon’s platform into endoluminal and metabolic applications.” 

Dr. Abu Dayyeh’s addition reinforces 𝗤𝗮𝗲𝗹𝗼𝗻’𝘀 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗲𝗻𝗱𝗼𝘀𝗰𝗼𝗽𝘆 𝗮𝘀 𝗮 𝗸𝗲𝘆 𝗴𝗿𝗼𝘄𝘁𝗵 𝗮𝗿𝗲𝗮 𝗮𝗻𝗱 𝗶𝘁𝘀 𝗰𝗼𝗺𝗺𝗶𝘁𝗺𝗲𝗻𝘁 𝘁𝗼 𝗮𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗱𝗮𝘁𝗮-𝗱𝗿𝗶𝘃𝗲𝗻 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗲𝗻𝗱𝗼𝗹𝘂𝗺𝗶𝗻𝗮𝗹 𝘀𝘂𝗿𝗴𝗲𝗿𝘆.

Qaelon Medical Eran Shlomovitz  Liam J. Burns  Lee Swanstrom

American Society for Gastrointestinal Endoscopy (ASGE)

American Gastroenterological Association (AGA)  

Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)